HeartSciences (HSCS) Accounts Payables (2022 - 2025)

HeartSciences (HSCS) has reported Accounts Payables for 4 consecutive years, with $318661.0 the latest figure, recorded in Q4 2025.

• Quarterly Accounts Payables changed N/A year-over-year to $318661.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $318661.0 (changed N/A YoY) and the FY2025 annual result came in at $318661.0, down 28.9% from the prior year.
• Accounts Payables was little changed at $318661.0 in Q4 2025 per HSCS's latest filing, from $317390.0 in the prior quarter.
• Over the last five years, Accounts Payables for HSCS reached as high as $1.1 million in Q4 2023 and fell as low as $276848.0 in Q4 2024.
• A 4-year average of $521285.9 and a median of $431629.5 in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables soared 36.85% — and 2024, when it tumbled 74.56%.
• Year by year, Accounts Payables stood at $795266.0 in 2022, then surged by 36.85% to $1.1 million in 2023, then slumped by 74.56% to $276848.0 in 2024, then advanced by 15.1% to $318661.0 in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $318661.0, $317390.0, and $283225.0 for Q4 2025, Q4 2025, and Q3 2025 respectively.